Inhibitory effects of Luobuma tea and its components against glucose-mediated protein damage

被引:136
作者
Yokozawa, T [1 ]
Nakagawa, T [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Inst Nat Med, Toyama 9300194, Japan
关键词
luobuma; advanced glycation endproducts; (+/-)-gallocatechin; (-)-epigallocatechin; (+/-)-catechin; (-)-epicatechin; epicatechin-(4 beta-8)-gallocatechin; epigallocatechin-(4 beta-8)-epicatechin; procyanidin B-2;
D O I
10.1016/j.fct.2004.02.010
中图分类号
TS2 [食品工业];
学科分类号
0832 [食品科学与工程];
摘要
Luobuma tea, prepared from the leaves of Apocynum venetum L., is a popular beverage in China. In this study, the activity of Luobuma leaf extract and its components against the formation of advanced glycation endproducts (AGEs), which are largely involved in the pathogenesis of diabetic vascular complications, was examined using the in vitro glycation reaction. Strong inhibitory activity against the formation of AGEs was shown by Luobuma aqueous extract. Following further fractionation of this extract, seven polyphenolic compounds, i.e. (+/-)-gallocatechin, (-)-epigallocatechin, (+/-)-catechin, (-)-epicatechin, epicatechin-(4beta-8)-gallocatechin, epigallocatechin-(4beta-8)-epicatechin and procyanidin B-2, were isolated by Sephadex LH-20 column chromatography. These purified compounds also exerted inhibitory activities that were more potent than the positive control, aminoguanidine. Our findings may help to explain the beneficial effects of this plant against atherosclerosis. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:975 / 981
页数:7
相关论文
共 36 条
[1]
Bucala R, 1992, Adv Pharmacol, V23, P1
[2]
LIPID ADVANCED GLYCOSYLATION - PATHWAY FOR LIPID OXIDATION IN-VIVO [J].
BUCALA, R ;
MAKITA, Z ;
KOSCHINSKY, T ;
CERAMI, A ;
VLASSARA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6434-6438
[3]
ADVANCED GLYCOSYLATION PRODUCTS QUENCH NITRIC-OXIDE AND MEDIATE DEFECTIVE ENDOTHELIUM-DEPENDENT VASODILATATION IN EXPERIMENTAL DIABETES [J].
BUCALA, R ;
TRACEY, KJ ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :432-438
[4]
Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships [J].
Cao, GH ;
Sofic, E ;
Prior, RL .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (05) :749-760
[5]
THE ROLE OF NONENZYMATIC GLYCOSYLATION, TRANSITION-METALS, AND FREE-RADICALS IN THE FORMATION OF COLLAGEN AGGREGATES [J].
CHACE, KV ;
CARUBELLI, R ;
NORDQUIST, RE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 288 (02) :473-480
[6]
High risk strategies for atherosclerosis [J].
Cullen, P ;
Assmann, G .
CLINICA CHIMICA ACTA, 1999, 286 (1-2) :31-45
[7]
ENDOTHELIAL RECEPTOR-MEDIATED BINDING OF GLUCOSE-MODIFIED ALBUMIN IS ASSOCIATED WITH INCREASED MONOLAYER PERMEABILITY AND MODULATION OF CELL-SURFACE COAGULANT PROPERTIES [J].
ESPOSITO, C ;
GERLACH, H ;
BRETT, J ;
STERN, D ;
VLASSARA, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1387-1407
[8]
Diabetes mellitus and coronary heart disease - from prevention to intervention: Part II [J].
Farouque, HMO ;
O'Brien, RC ;
Meredith, IT .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 2000, 30 (05) :608-617
[9]
Friedman EA, 1999, DIABETES CARE, V22, pB65
[10]
GLYCATION, GLYCOXIDATION, AND CROSS-LINKING OF COLLAGEN BY GLUCOSE - KINETICS, MECHANISMS, AND INHIBITION OF LATE STAGES OF THE MAILLARD REACTION [J].
FU, MX ;
WELLSKNECHT, KJ ;
BLACKLEDGE, JA ;
LYONS, TJ ;
THORPE, SR ;
BAYNES, JW .
DIABETES, 1994, 43 (05) :676-683